OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
OraSure Technologies (NASDAQ: OSUR) has scheduled its Q4 2024 earnings conference call for February 25, 2025, at 5 p.m. ET. The company will discuss fourth quarter financial results and business developments during the call.
A webcast will be available on OraSure's investor relations website, with registration required at least 10 minutes before the call. The webcast recording will be accessible for approximately 90 days after the event. Participants who wish to ask questions during the call must pre-register through a provided link to receive access details.
OraSure Technologies (NASDAQ: OSUR) ha programmato la sua conferenza sui risultati finanziari del Q4 2024 per il 25 febbraio 2025, alle 17:00 ET. Durante la chiamata, l'azienda discuterà i risultati finanziari del quarto trimestre e gli sviluppi aziendali.
Un webcast sarà disponibile sul sito web delle relazioni con gli investitori di OraSure, con registrazione richiesta almeno 10 minuti prima della chiamata. La registrazione del webcast sarà accessibile per circa 90 giorni dopo l'evento. I partecipanti che desiderano porre domande durante la chiamata devono pre-registrarsi tramite un link fornito per ricevere i dettagli di accesso.
OraSure Technologies (NASDAQ: OSUR) ha programado su conferencia de resultados financieros del Q4 2024 para el 25 de febrero de 2025, a las 5 p.m. ET. Durante la llamada, la empresa discutirá los resultados financieros del cuarto trimestre y los desarrollos comerciales.
Una transmisión web estará disponible en el sitio web de relaciones con inversores de OraSure, siendo necesaria la inscripción al menos 10 minutos antes de la llamada. La grabación de la transmisión estará accesible durante aproximadamente 90 días después del evento. Los participantes que deseen hacer preguntas durante la llamada deben preinscribirse a través de un enlace proporcionado para recibir los detalles de acceso.
OraSure Technologies (NASDAQ: OSUR)� 2025� 2� 25� 오후 5� ET� Q4 2024 실적 컨퍼런스 콜을 예정하고 있습니다. 회사� � 중에 4분기 재무 결과 � 사업 개발� 대� 논의� 것입니다.
웹캐스트� OraSure� 투자� 관� 웹사이트에서 제공되며, � 10� 전까지 사전 등록� 필요합니�. 웹캐스트 녹화� 행사 � � 90� 동안 접근� � 있습니다. � � 질문� 하고 싶은 참가자는 제공� 링크� 통해 사전 등록하여 접근 세부 정보� 받아� 합니�.
OraSure Technologies (NASDAQ: OSUR) a programmé sa conférence téléphonique sur les résultats financiers du T4 2024 pour le 25 février 2025 à 17h00 ET. L'entreprise discutera des résultats financiers du quatrième trimestre et des développements commerciaux lors de l'appel.
Un webinaire sera disponible sur le site Web des relations investisseurs d'OraSure, avec une inscription requise au moins 10 minutes avant l'appel. L'enregistrement du webinaire sera accessible pendant environ 90 jours après l'événement. Les participants souhaitant poser des questions lors de l'appel doivent se pré-enregistrer via un lien fourni pour recevoir les détails d'accès.
OraSure Technologies (NASDAQ: OSUR) hat seine Telefonkonferenz zu den Ergebnissen des 4. Quartals 2024 für den 25. Februar 2025 um 17:00 Uhr ET angesetzt. Das Unternehmen wird während des Anrufs die finanziellen Ergebnisse des vierten Quartals und die Geschäftsentwicklungen besprechen.
Ein Webcast wird auf der Investor-Relations-Website von OraSure verfügbar sein, wobei eine Registrierung mindestens 10 Minuten vor dem Anruf erforderlich ist. Die Aufzeichnung des Webcasts wird etwa 90 Tage nach der Veranstaltung zugänglich sein. Teilnehmer, die während des Anrufs Fragen stellen möchten, müssen sich über einen bereitgestellten Link vorregistrieren, um Zugangsinformationen zu erhalten.
- None.
- None.
BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET on February 25, 2025.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.
For participants interested in asking questions during the conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure�) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit
Investor Contact: Jason Plagman VP, Investor Relations [email protected] | Media Contact: Amy Koch Director, Corporate Communications [email protected] |
